针可以通过调节P2X7/ERK通路来缓解手术后的痛
Bin Chen1, Tian Wang2, Jie Gao3
1Department of Anorectal Surgery, Nantong First People's Hospital, Nantong, 226001, Jiangsu, China.
Purinergic signalling
|January 16, 2026
概括
在手术模型中,针有效地减少了术后疼痛和抑郁行为,通过准P2X7 / ERK通路并减少炎症. 这项研究强调P2X7受体是疼痛管理的关键治疗点.
科学领域:
- 神经科学是一个神经科学.
- 疼痛管理 疼痛管理
- 炎症研究 炎症研究
背景情况:
- 来自手术的术后疼痛通常涉及情绪和认知问题.
- 针在治疗疼痛和相关的神经炎症方面显示出潜力.
- P2X7受体及其信号通路与疼痛机制有关.
研究的目的:
- 在大鼠模型中研究针在缓解术后疼痛和相关行为障碍方面的疗效.
- 阐明P2X7/ERK信号通路在针缓解疼痛效果中的作用.
- 探索P2X7受体作为术后疼痛的潜在治疗点.
主要方法:
- 使用混合手术的老鼠模型,组接受针,假针或药理干预.
- 行为测试 (开放场地,糖糖偏好,·弗雷) 评估了运动活动,无情感和疼痛值.
- 采用ELISA,色度测试,RT-qPCR,西斑和免疫组织化学来测量背脊根质 (DRG) 中的炎症标记物,ATP和P2X7/ERK通路组件.
主要成果:
- 与对照组相比,针显著改善了运动活动,糖糖偏好和机械疼痛值.
- 针治疗降低了IL-6和TNF-α的水平,同时增加了DRG组织中的ATP度.
- 针抑制了P2X7和p-ERK表达的升高,P2X7抗剂A-438079验证了该途径的参与.
结论:
- 心理调节和缓解疼痛的针有效地缓解了手术后的疼痛和类似抑郁症的行为在白手术小鼠模型中.
- 治疗效果很可能是通过抑制外围P2X7 / ERK信号和相关炎症来调节的.
- P2X7受体是治疗术后疼痛的有前途的治疗标,强调了P2X受体的翻译相关性.
相关概念视频
01:23Peripheral Artery Disease V: Postoperative Nursing Management
378
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
378
01:25Analgesia and Pain Management
1.5K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.5K
01:17Drugs for Treatment of Diarrhea-Predominant IBS
635
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
635
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
931
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
931